Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/20351
Title: Elderly patients with stage III NSCLC survive longer when chemotherapy is added to radiotherapy-fortune favours the bold.
Austin Authors: Arulananda, Surein;Mitchell, Paul L R 
Affiliation: School of Cancer Medicine, La Trobe University, Heidelberg, Australia
Department of Medical Oncology, Austin Health, Heidelberg, Victoria, Australia
Department of Medicine, University of Melbourne, Parkville, Australia
Cancer Immuno-Biology Laboratory, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
Issue Date: Dec-2018
Publication information: Translational lung cancer research 2018; 7(Suppl 4): S388-S392
URI: http://ahro.austin.org.au/austinjspui/handle/1/20351
DOI: 10.21037/tlcr.2018.08.12
ORCID: 0000-0002-5636-6381
PubMed URL: 30705864
ISSN: 2218-6751
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.